Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer
T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy
Observation of Medical Treatments in MBC HER2-negative Patients
Trastuzumab in Treating Women With Primary Breast Cancer
† Study has passed its completion date and status has not been verified in more than two years.